4//SEC Filing
Goeltz II Robert C. 4
Accession 0001724521-25-000002
CIK 0001724521other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 4:08 PM ET
Size
4.8 KB
Accession
0001724521-25-000002
Insider Transaction Report
Form 4
Goeltz II Robert C.
Chief Financial Officer
Transactions
- Sale
Common Stock
2024-12-31$15.00/sh−3,594$53,910→ 60,138 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 7, 2023.
Documents
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
Related Parties
1- filerCIK 0001653881
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 4:08 PM ET
- Size
- 4.8 KB